Optimal control applied to immunotherapy
From MaRDI portal
Recommendations
- Dynamics of tumor-immune interaction under treatment as an optimal control problem
- The combined effects of optimal control in cancer remission
- OPTIMAL CONTROL OF MIXED IMMUNOTHERAPY AND CHEMOTHERAPY OF TUMORS
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
- An optimal control approach to cancer treatment under immunological activity
Cited in
(65)- Effect of awareness programs and travel-blocking operations in the control of HIV/AIDS outbreaks: a multi-domains SIR model
- Optimization of combined leukemia therapy by finite-dimensional optimal control modeling
- Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine
- The combined effects of optimal control in cancer remission
- Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors
- Stochastic optimal therapy for enhanced immune response
- Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach
- Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach
- Optimal control with isoperimetric constraint for chemotherapy of tumors
- Chemotherapy and immunotherapy for tumors: a study of quadratic optimal control
- Metaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparison
- A cellular automata model of tumor-immune system interactions
- Optimization of interleukin-21 immunotherapeutic strategies
- Cancer immunotherapy, mathematical modeling and optimal control
- Optimal CAR T-cell immunotherapy strategies for a leukemia treatment model
- Optimal control analysis of a leukemia model under Imatinib treatment
- Dynamics of tumor-immune interaction under treatment as an optimal control problem
- Optimal treatment strategy for a tumor model under immune suppression
- Optimal control strategies for a two-group epidemic model with vaccination-resource constraints
- Immune therapeutic strategies using optimal controls with \(L^{1}\) and \(L^{2}\) type objectives
- Modeling pancreatic cancer dynamics with immunotherapy
- Stability analysis of a mathematical model for glioma-immune interaction under optimal therapy
- A set-valued approach to control immunotherapy
- Smooth solutions of the Hamilton-Jacobi-Bellman equation in a mathematical model of optimal treatment of viral infections
- Determination of the optimal therapeutic protocols in cancer immunotherapy
- Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls
- Optimal control of the dynamics of a tumor growth model with Hollings' type-II functional response
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
- Optimal control of effector-tumor-normal cells dynamics in presence of adoptive immunotherapy
- An optimal control problem of immuno-chemotherapy in presence of gene therapy
- Quadratic and linear controls developing an optimal treatment for the use of BCG immunotherapy in superficial bladder cancer
- A mathematical model of gene therapy for the treatment of cancer
- Therapy strategy in tumour cells and immune system interaction mathematical model
- Delay dynamics of cancer and immune cell model
- Optimization for the intensive treatment of leukemia
- An optimal control approach to cancer treatment under immunological activity
- Optimal control of antigen-antibody interactions for cancer immunotherapy
- A control theory approach to cancer remission aided by an optimal therapy
- Optimal control problem in an epidemic disease SIS model with stages and delays
- Controlled drug delivery in cancer immunotherapy: stability, optimization, and Monte Carlo analysis
- OPTIMAL CONTROL OF MIXED IMMUNOTHERAPY AND CHEMOTHERAPY OF TUMORS
- A unified set-valued approach to control immunotherapy
- Optimal multitherapy strategy in mathematical model of dynamics of the number of nonuniform tumor cells
- Optimal controls for a mathematical model of tumor-immune interactions under targeted chemotherapy with immune boost
- Numerical solution of an optimal control model of dendritic cell treatment of a growing tumour
- Optimal duration and dosage of BCG intravesical immunotherapy: A free final time optimal control approach
- Optimal control model of immunotherapy for autoimmune diseases
- Bifurcation analysis of a delayed mathematical model for tumor growth
- A switching control law approach for cancer immunotherapy of an evolutionary tumor growth model
- Model for transmission and optimal control of anthrax involving human and animal population
- The impact of infected T lymphocyte burst rate and viral shedding rate on optimal treatment scheduling in a human immunodeficiency virus infection
- Optimal control analysis of combined chemotherapy-immunotherapy treatment regimens in a PKPD cancer evolution model
- A tumor-immune model with mixed immunotherapy and chemotherapy: qualitative analysis and optimal control
- Tumor control, elimination, and escape through a compartmental model of dendritic cell therapy for melanoma
- Analysis of tumor/effector cell dynamics and decision support in therapy
- A strategy of optimal efficacy of T11 target structure in the treatment of brain tumor
- Synthesis of optimal control in a mathematical model of tumour-immune dynamics
- Feedback Spreading Control Applied to Immunotherapy
- STOCHASTIC DYNAMICS BETWEEN THE IMMUNE SYSTEM AND CANCER CELLS WITH ALLEE EFFECT AND IMMUNOTHERAPY
- Modeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependent
- Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics
- Free end-time optimal control problem for cancer chemotherapy
- A computational approach for understanding immune response to multiple epitopes based on optimal control formulation
- Stochastic control model for chemotherapy of cancer
- Failure of antibiotic treatment in microbial populations
This page was built for publication: Optimal control applied to immunotherapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1430351)
